Sign in

CIK 0001817713 · Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822289112
Phone
(858) 751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
  1. 4 Insider Changes in Ownership
  2. 8-K Event Other events
  3. 424B5 Offering Prospectus
  4. 4 Insider Changes in Ownership
  5. 424B5 Offering Prospectus
  6. 8-K Event Regulation FD disclosure · Other events
  7. 4 Insider Changes in Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13D/A Stake Beneficial Ownership Report
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 7 of 23 · 442 filings